Skip to main content

Table 2 Univariate analysis: local control survival for OLTs from CRC and early stage NSCLC

From: A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer

Factors

CRC

NSCLC

p

95% CI

p

95% CI

Age

0.31

0.10–1.15

0.85

0.83–1.17

Location

0.34

0.42–1.35

0.34

0.09–2.3

Tumor size

0.72

0.07–6.39

0.95

0.05–23.41

RT dose (BED10)

0.02

1.35–53.89

0.15

0.76–5.87

Baseline SUVmax

0.38

0.42–1.38

0.47

0.82–1.53

KRAS-mutation status

0.23

0.00–16.83

–

Â